Clinical Trial Update: Progesterone Supplementation on Women Having Low Progesterone Levels on Transfer Day [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating progesterone supplementation in women with low progesterone on transfer day during assisted reproductive technology.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Assisted Reproductive Technology Outcomes
• Infertility

Drugs mentioned

• PROGESTERONE (Progesterone)

Snippet

Sponsor: Tu Du Hospital | Conditions: Assisted Reproductive Technology | Phase 3 | Status: UNKNOWN